Claritev
CTEV

Claritev (CTEV) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysMaintainedOverweight$40.00 from $28.00Aug 21, 2026
Wells FargoMaintainedEqual-Weight$30.00 from $22.00Aug 12, 2026
Canaccord GenuityMaintainedBuy$43.00 from $37.00Aug 10, 2026
CitigroupMaintainedBuy$45.00 from $40.00Aug 10, 2026
Canaccord GenuityMaintainedBuy$37.00 from $32.00Jul 21, 2026
Canaccord GenuityInitiated CoverageBuy$32.00May 29, 2026
BarclaysInitiated CoverageOverweight$28.00Apr 24, 2026
Wells FargoMaintainedEqual-Weight$22.00 from $30.00Mar 19, 2026
CitigroupMaintainedBuy$21.00 from $63.00Feb 25, 2026
GuggenheimMaintainedBuy$38.00 from $43.00Feb 24, 2026
Wells FargoMaintainedEqual-Weight$30.00 from $33.00Feb 24, 2026
CitigroupMaintainedBuy$63.00 from $80.00Jan 9, 2026
Wells FargoInitiated CoverageEqual-Weight$33.00Jan 9, 2026
CitigroupMaintainedBuy$80.00 from $74.00Nov 10, 2025
CitigroupUpgradedNeutral → Buy$74.00 from $55.00Oct 22, 2025
CitigroupUpgradedNeutral → Buy$55.00Oct 21, 2025
Piper SandlerMaintainedOverweight$86.00 from $44.00Aug 15, 2025
Piper SandlerUpgradedNeutral → Overweight$44.00 from $19.00May 29, 2025
Piper SandlerMaintainedNeutral$19.00 from $10.00Mar 10, 2025
CitigroupMaintainedNeutral$12.50 from $10.00Jan 10, 2025

Frequently asked questions

  • What is the latest analyst rating on CTEV?

    On Aug 21, 2026, Barclays maintained Claritev at Overweight with a price target of $40.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.